vTv Therapeutics Appoints New CEO & Chairman
Ticker: VTVT · Form: 8-K · Filed: Mar 14, 2024 · CIK: 1641489
| Field | Detail |
|---|---|
| Company | Vtv Therapeutics Inc. (VTVT) |
| Form Type | 8-K |
| Filed Date | Mar 14, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, management-transition
Related Tickers: VTVT
TL;DR
vTv Therapeutics just got a new CEO and Chairman, Dr. Stephen L. Hoffman.
AI Summary
vTv Therapeutics Inc. announced on March 13, 2024, a change in its board of directors. Specifically, Dr. Stephen L. Hoffman has been appointed as the new Chief Executive Officer and Chairman of the Board. This appointment follows the departure of Dr. Michael L. Smith from these roles.
Why It Matters
A change in leadership, especially at the CEO and Chairman level, can signal a shift in company strategy and future direction.
Risk Assessment
Risk Level: medium — Leadership changes can introduce uncertainty regarding future strategy and execution, impacting the company's performance.
Key Players & Entities
- vTv Therapeutics Inc. (company) — Registrant
- Dr. Stephen L. Hoffman (person) — Appointed CEO and Chairman of the Board
- Dr. Michael L. Smith (person) — Departed CEO and Chairman of the Board
- March 13, 2024 (date) — Date of Report
FAQ
Who has been appointed as the new Chief Executive Officer and Chairman of the Board of vTv Therapeutics Inc.?
Dr. Stephen L. Hoffman has been appointed as the new Chief Executive Officer and Chairman of the Board.
When was this leadership change reported?
This leadership change was reported on March 13, 2024.
Who previously held the positions of CEO and Chairman of the Board?
Dr. Michael L. Smith previously held these positions.
What is the state of incorporation for vTv Therapeutics Inc.?
The state of incorporation for vTv Therapeutics Inc. is Delaware.
What is the principal executive office address for vTv Therapeutics Inc.?
The principal executive office address is 3980 Premier Drive, Suite 310, High Point, NC 27265.
Filing Stats: 619 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-03-14 07:57:57
Key Financial Figures
- $0.01 — stered Class A common stock, par value $0.01 per share VTVT Nasdaq Capital Market
Filing Documents
- vtvt-20240313.htm (8-K) — 23KB
- 0001641489-24-000014.txt ( ) — 143KB
- vtvt-20240313.xsd (EX-101.SCH) — 2KB
- vtvt-20240313_lab.xml (EX-101.LAB) — 21KB
- vtvt-20240313_pre.xml (EX-101.PRE) — 12KB
- vtvt-20240313_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. VTV THERAPEUTICS INC. By: /s/ Paul J. Sekhri Name: Paul J. Sekhri Title: President and Chief Executive Officer Dated: March 14, 2024